489
Views
1
CrossRef citations to date
0
Altmetric
Original

URATE HOMEOSTASIS IN POLYCYSTIC KIDNEY DISEASE: COMPARISON WITH CHRONIC GLOMERULONEPHRITIC KIDNEY

, M.D., &
Pages 447-459 | Published online: 07 Jul 2009

REFERENCES

  • Grantham J.J. Polycystic Kidney Disease: A Predominance of Giant Nephrons. Am. J. Physiol. 1983; 244: F3–F10
  • Wilson P.D., Gabow P.A., Palla K., Norman J.T. Alterations in Membrane Na-K-ATPase in Adult Human Polycystic Kidney Disease (ADKD). Kidney Int. 1989; 35: 167, abstr
  • Steele T.H., Rieselbach R.E. The Renal Mechanism for Urate Homeostasis in Normal Man. Am. J. Med. 1967; 43: 868–875
  • Diamond H.S., Paolino J.S. Evidence for a Postsecretory Reabsorptive Site for Uric Acid in Man. J. Clin. Invest. 1973; 52: 1491–1499
  • Rivera J.A., Martinez-Maldonado M., Ramirez de Arellano G., Ehrlich L. Association of Hyperuricemia and Polycystic Kidney Disease. Bol. Ass. Med. PR. 1965; 5: 251–262
  • Newcombe D.S. Gouty Arthritis and Polycystic Kidney Disease. Ann. Intern. Med. 1973; 79: 605, letter
  • Gabow A.P., Ilke W.D., Holmes H.J. Polycystic Kidney Disease: Prospective Analysis of Nonazotemic Patients and Family Members. Ann. Intern. Med. 1984; 101: 238–247
  • Martinez-Maldolado M. General Features of Autosomal Dominant Polycystic Kidney Disease. Functional Aspects. Electrolyte and Uric Acid Excretion. Problems in Diagnosis and Management of Polycystic Kidney Disease, J.J. Grantham, D.K. Gardner. PKR Foundation, Kansas City 1985; 70–86
  • Mejias E., Navas J., Lluberes R., Martinez-Maldonado M. Hyperuricemia, Gout, and Autosomal Dominant Polycystic Kidney Disease. Am. J. Med. Sci. 1989; 296: 145–148
  • Kaehny W.D., Tangel D.J., Johnson A.M., Kiberling W.J., Schrier R.W., Gabow P.A. Uric Acid Handling in Autosomal Dominant Polycystic Kidney Disease with Normal Filtration Rates. Am. J. Med. 1990; 89: 49–52
  • Massarj P., Holtz M.R. Renal Handling of Uric Acid in Polycystic Kidney Disease (PKD). Abstracts of XI International Congress of Nephrology, Tokyo, 1990, 149A
  • Garyfallos A., Magoula I., Tsapas G. Evaluation of the Renal Mechanisms for Urate Homeostasis in Uremic Patients by Probenecid and Pyrazinamide Test. Nephron 1987; 46: 273–280
  • Steele T.H., Rieselbach R.E. The Contribution of Residual Nephrons Within the Chronically Diseased Kidney to Urate Homeostasis in Man. Am. J. Med. 1967; 43: 876–886
  • Grantham J.J., Chonko A.M. Renal Handling of Organic Anions and Cations; Excretion of Uric Acid. The Kidney, B.M. Brenner, F.C. Rector. WB Saunders, Philadelphia 1991; 483–509, Chapter 13
  • Diamond H.S. Interpretation of Pharmacologic Manipulation of Urate Transport in Man. Nephron 1989; 51: 1–5
  • Magoula I., Tsapas G., Garyfallos A., Kountouras I. Hypouricemia in Liver Cell Carcinoma: An Isolated Tubular Defect. Am. J. Med. 1987; 83: 196, letter
  • Puig J.G., Anton F.M., Sanz A.M. Renal Handling of Uric Acid in Normal Subjects by Means of the Pyrazinamide and Probenecid Tests. Nephron 1983; 35: 183–186
  • Gutman A.B., Yu T., Berger L. Renal Function in Gout. III. Estimation of Tubular Secretion and Reabsorption of Uric Acid by Use Pyrazinoic Acid (Pyrazinamide). Am. J. Med. 1969; 47: 575–592
  • Diamond H.S., Meisel A., Sharon E., Holden D., Cacatian A. Hyperuricosuria and Increased Tubular Secretion of Urate in Sickle Cell Anemia. Am. J. Med. 1975; 59: 796–802
  • Schichiri M., Matsuda M.D., Shigai T., Takeuchi J., Kanayama M. Hypouricemia Due to an Increment in Renal Tubular Secretion. Arch. Int. Med. 1982; 142: 1855–1857
  • Magoula I., Tsapas G., Paletas K., Mavromatidis K. Insulin Dependent Diabetes and Renal Hypouricemia. Nephron 1991; 59: 21–26
  • Magoula I., Tsapas G., Kountouras J., Paletas K. Cholangiocarcinoma and Severe Renal Hypouricemia: A Study of the Renal Mechanisms. Am. J. Kidney Dis. 1991; 18: 514–519
  • Magoula I., Tsapas G., Paletas K., Ziogas G. Effects of Angiotensin Converting Enzyme (ACE) Inhibitors on Renal Urate Clearance (Clur). Kidney Int. 1991; 39: 195, abstr
  • Weiner I.M., Tinker J.P. Pharmacology of Pyrazinamide: Metabolic and Renal Function Studies Related to the Mechanism of Drug-Induced Urate Retention. J. Pharmacol. Exp. Ther. 1972; 180: 411–434
  • Lang F., Greger R., Oberleithner H. Renal Handling of Urate in Healthy Man in Hyperuricemia and Renal Insufficiency: Circadian Fluctuation, Effect of Water Diuresis and Uricosuric Agents. Eur. J. Clin. Invest. 1980; 10: 285–292
  • Danovich G.M., Weinberger J., Berlyne G.M. Uric Acid in Advanced Renal Failure. Clin. Sci. 1972; 43: 331–341
  • Koch-Wesel J., Sellers E.M. Drug Therapy. Binding of Drugs to Serum Albumin. N. Engl. J. Med. 1976; 294: 311–316
  • Ferris T.F., Gorgen P. Effect of Angiotensin and Norepinephrine Upon Urate Clearance in Man. Am. J. Med. 1968; 44: 359–365
  • Sorensen S.S., Glud T.K., Sorensen P.J., Amdisen A., Pedersen E.B. Change in Renal Tubular Sodium and Water Handling During Progression of Polycystic Kidney Disease: Relationship to Atrial Natriuretic Peptide. Nephrol. Dial. Transplant 1990; 5: 247–257

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.